Peritoneal Cancer
📧 Sign up to get email alerts when something new happens for Peritoneal Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-06-20Clinical Trial Update: Vaccine Therapy in Treating Patients With Ovarian Epithelial or Primary Peritoneal Cancer [Phase 1]
This Phase 1 trial studied a vaccine therapy in patients with ovarian epithelial cancer or primary peritoneal cancer; the study is completed…
-
CLINICAL_TRIALS trial_result · 2014-06-19Clinical Trial Update: Oxaliplatin, Gemcitabine and Bevacizumab in Women With Recurrent Mullerian Carcinoma [Phase 2]
Phase 2 trial evaluating oxaliplatin, gemcitabine, and bevacizumab in women with recurrent Mullerian carcinomas; the study (NCT00418093) was…
-
CLINICAL_TRIALS trial_result · 2014-06-18Clinical Trial Update: Mifepristone in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer [Phase 2]
A Phase 2 trial evaluating mifepristone for recurrent or persistent ovarian epithelial, primary peritoneal, or fallopian tube cancer has com…
-
CLINICAL_TRIALS trial_result · 2014-06-12Clinical Trial Update: Early Post-Operative Enteral Feeding in Patients With Advanced Epithelial Ovarian Cancer [Phase 3]
This Phase 3 trial evaluated early post-operative enteral feeding in patients with advanced epithelial ovarian cancer, including peritoneal …
-
CLINICAL_TRIALS trial_result · 2014-05-14Clinical Trial Update: Bevacizumab and Erlotinib in Treating Patients With Recurrent or Metastatic Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer [Phase 2]
A Phase 2 trial evaluating the combination of Bevacizumab and Erlotinib in patients with recurrent or metastatic ovarian epithelial cancer, …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-03-07Clinical Trial Update: Randomized Multicenter Trial With SU11248 Evaluating Dosage,Tolerability,Toxicity and Effectiveness of a Multitargeted Receptor Tyrosine Kinase Inhibitor [Phase 2]
Phase 2 randomized multicenter trial evaluating SU11248 (sunitinib) in platinum-refractory epithelial ovarian cancer and peritoneal cancers,…
-
CLINICAL_TRIALS trial_result · 2014-02-24Clinical Trial Update: AFP464 in Treating Patients With Metastatic or Refractory Solid Tumors That Cannot Be Removed By Surgery [Phase 1]
Phase 1 study evaluating AFP464 in patients with metastatic or unresectable solid tumors completed; the trial enrolled patients with various…
-
CLINICAL_TRIALS trial_result · 2014-02-14Clinical Trial Update: Pemetrexed Disodium in Treating Patients With Ovarian Epithelial Cancer or Primary Peritoneal Cancer [Phase 2]
A Phase 2 trial evaluating pemetrexed disodium for ovarian cancer and primary peritoneal cancer has completed.
-
CLINICAL_TRIALS trial_result · 2014-02-14Clinical Trial Update: Cetuximab and Carboplatin in Treating Patients With Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer [Phase 2]
Phase 2 trial evaluating cetuximab in combination with carboplatin for recurrent ovarian epithelial cancer or primary peritoneal cancer; the…
-
CLINICAL_TRIALS trial_result · 2014-02-04Clinical Trial Update: Study of Paclitaxel in Patients With Ovarian Cancer [Phase 3]
A Phase 3 trial evaluating paclitaxel in patients with epithelial ovarian cancer, primary peritoneal cancer, and fallopian tube cancer has c…
-
CLINICAL_TRIALS trial_result · 2014-01-21Clinical Trial Update: Belinostat and Carboplatin in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer That Did Not Respond to Carboplatin or Cisplatin [Phase 2]
Phase 2 trial evaluating belinostat plus carboplatin in recurrent or persistent carboplatin/ cisplatin–refractory ovarian epithelial, fallop…
-
CLINICAL_TRIALS research · 2014-01-06Clinical Trial Update: Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Persistent Epithelial Ovarian Cancer, Fallopian Tube, or Primary Peritoneal Cancer [Phase 1, Phase 2]
This clinical trial update covers a phase 1/2 study of combination chemotherapy with peripheral stem cell transplantation for recurrent or p…
-
CLINICAL_TRIALS trial_result · 2014-01-06Clinical Trial Update: Docetaxel Plus Carboplatin in Treating Patients With Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 2]
This Phase 2 clinical trial update describes a study of docetaxel plus carboplatin for patients with Stage III or IV ovarian, fallopian tube…
-
CLINICAL_TRIALS withdrawal · 2013-12-20Clinical Trial Update: Safety and Efficacy Study of Gemcitabine Plus Bevacizumab in Patients With Platinum-Resistant Ovarian, Primary Peritoneal or Fallopian Tube Cancer [Phase 2]
A Phase 2 safety and efficacy study of gemcitabine plus bevacizumab for platinum-resistant ovarian, fallopian tube, or primary peritoneal ca…
-
CLINICAL_TRIALS trial_result · 2013-12-19Clinical Trial Update: CP-547,632 in Treating Patients With Recurrent or Persistent Ovarian Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer [Phase 2]
A Phase 2 study evaluating CP-547,632 in recurrent or persistent ovarian cancer, fallopian tube cancer, and primary peritoneal cancer has co…
-
CLINICAL_TRIALS trial_result · 2013-12-19Clinical Trial Update: Irofulven in Treating Patients With Recurrent or Persistent Ovarian Epithelial or Primary Peritoneal Cancer [Phase 2]
Phase 2 clinical trial evaluating irofulven in recurrent or persistent ovarian epithelial cancer and primary peritoneal cancer; study comple…
-
CLINICAL_TRIALS research · 2013-12-19Clinical Trial Update: Platinum-based Chemotherapy With or Without Paclitaxel in Treating Patients With Relapsed Ovarian Cancer [Phase 3]
A Phase 3 clinical trial evaluating platinum-based chemotherapy with or without paclitaxel for relapsed ovarian cancer and primary peritonea…
-
CLINICAL_TRIALS trial_result · 2013-12-19Clinical Trial Update: Carboplatin Plus Paclitaxel or Docetaxel in Treating Patients With Ovarian Epithelial Cancer [Phase 3]
A Phase 3 clinical trial comparing carboplatin plus paclitaxel versus carboplatin plus docetaxel in ovarian cancer has completed.
-
CLINICAL_TRIALS withdrawal · 2013-12-18Clinical Trial Update: Vaccine Therapy and IDO1 Inhibitor INCB024360 in Treating Patients With Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Who Are in Remission [Phase 1, Phase 2]
Withdrawal of a Phase 1/2 trial evaluating a cancer vaccine therapy in combination with the IDO1 inhibitor epacadostat (INCB024360) for epit…
-
CLINICAL_TRIALS trial_result · 2013-12-10Clinical Trial Update: Eribulin Mesylate in Treating Patients With Recurrent Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer [Phase 2]
Phase 2 trial evaluating eribulin mesylate in patients with recurrent ovarian epithelial cancer, fallopian tube cancer, or primary peritonea…
-
CLINICAL_TRIALS trial_result · 2013-12-04Clinical Trial Update: Early Chemotherapy Based on CA 125 Level Alone Compared With Delayed Chemotherapy in Treating Patients With Recurrent Ovarian Epithelial , Fallopian Tube, or Primary Peritoneal Cancer [Phase 3]
Phase 3 trial comparing early chemotherapy based on CA 125 levels versus delayed chemotherapy in recurrent ovarian epithelial, fallopian tub…
-
CLINICAL_TRIALS trial_result · 2013-11-26Clinical Trial Update: Hu3S193 in Treating Women With Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer [Phase 2]
Phase 2 trial evaluating Hu3S193 in women with ovarian epithelial, primary peritoneal, or fallopian tube cancer has completed, and results h…
-
CLINICAL_TRIALS trial_result · 2013-11-20Clinical Trial Update: Bortezomib in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer [Phase 2]
Phase 2 trial evaluating bortezomib in patients with persistent or recurrent ovarian epithelial cancer or primary peritoneal cancer has comp…
-
CLINICAL_TRIALS trial_result · 2013-11-20Clinical Trial Update: Temsirolimus in Treating Patients With Refractory or Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer [Phase 2]
Phase 2 trial update of temsirolimus in refractory or recurrent ovarian epithelial, fallopian tube, or primary peritoneal cancer; results po…
-
CLINICAL_TRIALS trial_result · 2013-11-08Clinical Trial Update: S0025 Irinotecan in Treating Patients With Refractory Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer [Phase 2]
A Phase 2 clinical trial evaluating irinotecan in patients with refractory ovarian epithelial, primary peritoneal, or fallopian tube cancer …